Hamilton Thorne Ltd
XTSX:HTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Hamilton Thorne Ltd
Cost of Revenue
Hamilton Thorne Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hamilton Thorne Ltd
XTSX:HTL
|
Cost of Revenue
-$29.1m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cost of Revenue
-$6.4B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-11%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cost of Revenue
-$1.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-8%
|
|
|
Stryker Corp
NYSE:SYK
|
Cost of Revenue
-$8.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cost of Revenue
-$19.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cost of Revenue
-$3.4B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-16%
|
|
Hamilton Thorne Ltd
Glance View
Hamilton Thorne Ltd. engages in the provision of laboratory instruments, consumables, software and services to the assisted reproductive technology (ART) and developmental biology research markets. The company is headquartered in Beverly, Massachusetts. The company went IPO on 2007-07-10. The firm's products lines include precision laser devices, imaging systems, micromanipulation systems, air purification systems, incubators, control rate freezers, and lab monitoring systems. Its GM501 product provides the In Vitro Fertilization (IVF)lab with a cell culture media solution, including oocyte handling, sperm processing, embryo culture, and cryopreservation. Its services offers a range of user needs, ranging from equipment service contract and maintenance programs, quality control testing services to manufacturers of medical devices, culture media and consumables used in IVF labs, and laboratory design and installation services. The firm's brands include Hamilton Thorne, Gynemed, Planer, IVFtech, Embryotech Laboratories, and Tek-Event.
See Also
What is Hamilton Thorne Ltd's Cost of Revenue?
Cost of Revenue
-29.1m
USD
Based on the financial report for Dec 31, 2022, Hamilton Thorne Ltd's Cost of Revenue amounts to -29.1m USD.
What is Hamilton Thorne Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-27%
Over the last year, the Cost of Revenue growth was -11%. The average annual Cost of Revenue growth rates for Hamilton Thorne Ltd have been -21% over the past three years , -27% over the past five years .
